<VariationArchive RecordType="classified" VariationID="2783" VariationName="NM_000158.4(GBE1):c.(992+1_993-1)_(1618+1_1619-1)del (p.Ser331Argfs)" VariationType="Deletion" Accession="VCV000002783" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-03-18" DateCreated="2013-10-01" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17822" VariationID="2783">
      <GeneList>
        <Gene Symbol="GBE1" FullName="1,4-alpha-glucan branching enzyme 1" GeneID="2632" HGNC_ID="HGNC:4180" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="81489703" stop="81761645" display_start="81489703" display_stop="81761645" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="81538849" stop="81810949" display_start="81538849" display_stop="81810949" Strand="-" />
          </Location>
          <OMIM>607839</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000158.4(GBE1):c.(992+1_993-1)_(1618+1_1619-1)del (p.Ser331Argfs)</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" outerStart="81537095" innerStart="81577925" innerStop="81594023" outerStop="81642781" display_start="81537095" display_stop="81642781" variantLength="16099" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" outerStart="81586246" innerStart="81627076" innerStop="81643174" outerStop="81691932" display_start="81586246" display_stop="81691932" variantLength="16099" />
      </Location>
      <OtherNameList>
        <Name>c.992_1619del</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.(81586247_81627075)_(81643175_81691931)del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.(81586247_81627075)_(81643175_81691931)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.(81537096_81577924)_(81594024_81642780)del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.(81537096_81577924)_(81594024_81642780)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011810.2" sequenceAccession="NG_011810" sequenceVersion="2" change="g.(123865_172621)_(188721_229549)del">
            <Expression>NG_011810.2:g.(123865_172621)_(188721_229549)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000158.4" sequenceAccession="NM_000158" sequenceVersion="4" change="c.(992+1_993-1)_(1618+1_1619-1)del" MANESelect="true">
            <Expression>NM_000158.4:c.(992+1_993-1)_(1618+1_1619-1)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv7487146" DB="dbVar" />
        <XRef ID="nsv1197564" DB="dbVar" />
        <XRef Type="Allelic variant" ID="607839.0008" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">In December, 2022, the description of this allele was corrected to represent the boundaries of the deletion within the introns instead of into the exon. In other words, the previous positions were off by 1.</Comment>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff determined the genomic coordinates for the outer extents of this deletion based on the sequence across the breakpoint of the resultant cDNA reported in PubMed 15019703.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000158.4(GBE1):c.(992+1_993-1)_(1618+1_1619-1)del (p.Ser331Argfs) AND Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form" Accession="RCV000002917" Version="4">
        <ClassifiedConditionList TraitSetID="712">
          <ClassifiedCondition DB="MedGen" ID="C1856304">Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000158.4(GBE1):c.(992+1_993-1)_(1618+1_1619-1)del (p.Ser331Argfs) AND Glycogen storage disease, type IV" Accession="RCV000056163" Version="2">
        <ClassifiedConditionList TraitSetID="6269">
          <ClassifiedCondition DB="MedGen" ID="C0017923">Glycogen storage disease, type IV</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-04-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2009-04-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-10-01" MostRecentSubmission="2022-12-31">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15019703</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301758</ID>
          <ID Source="BookShelf">NBK5300</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6269" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5200" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type IV</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+4/3124" DB="Genetic Alliance" />
                <XRef ID="11179002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GBE1 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOGENOSIS IV</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IV</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease due to glycogen branching enzyme deficiency</ElementValue>
                <XRef ID="MONDO:0009292" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Brancher deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amylopectinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen branching enzyme deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cirrhosis, familial, with deposition of abnormal glycogen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 4</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD4</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of glycogen storage disease type IV (GSD IV) discussed in this entry span a continuum of different subtypes with variable ages of onset, severity, and clinical features. Clinical findings vary extensively both within and between families. The fatal perinatal neuromuscular subtype presents in utero with fetal akinesia deformation sequence, including decreased fetal movements, polyhydramnios, and fetal hydrops. Death usually occurs in the neonatal period. The congenital neuromuscular subtype presents in the newborn period with profound hypotonia, respiratory distress, and dilated cardiomyopathy. Death usually occurs in early infancy. Infants with the classic (progressive) hepatic subtype may appear normal at birth, but rapidly develop failure to thrive; hepatomegaly, liver dysfunction, and progressive liver cirrhosis; hypotonia; and cardiomyopathy. Without liver transplantation, death from liver failure usually occurs by age five years. Children with the non-progressive hepatic subtype tend to present with hepatomegaly, liver dysfunction, myopathy, and hypotonia; however, they are likely to survive without progression of the liver disease and may not show cardiac, skeletal muscle, or neurologic involvement. The childhood neuromuscular subtype is rare and the course is variable, ranging from onset in the second decade with a mild disease course to a more severe, progressive course resulting in death in the third decade.</Attribute>
                <XRef ID="NBK115333" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23285490</ID>
                <ID Source="BookShelf">NBK115333</ID>
              </Citation>
              <XRef ID="367" DB="Orphanet" />
              <XRef ID="C0017923" DB="MedGen" />
              <XRef ID="MONDO:0009292" DB="MONDO" />
              <XRef Type="MIM" ID="232500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="712" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9812" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD IV, NEUROMUSCULAR FORM, CONGENITAL</ElementValue>
                <XRef ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form</ElementValue>
                <XRef ID="MONDO:0017698" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease IV, congenital neuromuscular</ElementValue>
                <XRef ID="GLYCOGEN+STORAGE+DISEASE+IV%2C+CONGENITAL+NEUROMUSCULAR/8482" DB="Genetic Alliance" />
              </Name>
              <XRef ID="308670" DB="Orphanet" />
              <XRef ID="C1856304" DB="MedGen" />
              <XRef ID="MONDO:0017698" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23075" SubmissionDate="2017-04-26" DateLastUpdated="2022-12-31" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607839.0008_GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR" title="GBE1, 627-BP DEL, EX8-12DEL_GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR" />
        <ClinVarAccession Accession="SCV000023075" DateUpdated="2022-12-31" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with the fatal congenital neuromuscular form of glycogen storage disease IV (GSD4; 232500), Tay et al. (2004) identified a homozygous 627-bp deletion in the GBE1 gene, resulting in the deletion of exons 8-12. Residual branching enzyme activity was 0.8% of normal. The parents were related and had a previous intrauterine death associated with decreased fetal movements and polyhydramnios. The patient died at 5.5 weeks of age.</Attribute>
              <Citation>
                <ID Source="PubMed">15019703</ID>
              </Citation>
              <XRef DB="OMIM" ID="232500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GBE1" />
          </GeneList>
          <Name>GBE1, 627-BP DEL, EX8-12DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">627-BP DEL, EX8-12DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607839.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="145984" SubmissionDate="2013-04-30" DateLastUpdated="2013-10-01" DateCreated="2013-10-01">
        <ClinVarSubmissionID localKey="c.992_1619del_NBK5300" title="c.992_1619del and Adult Polyglucosan Body Disease" />
        <ClinVarAccession Accession="SCV000087248" DateUpdated="2013-10-01" DateCreated="2013-10-01" Type="SCV" Version="1" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-04-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="nucleotide change">c.992_1619del</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Adult Polyglucosan Body Disease</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK5300" />
            <XRef DB="OMIM" ID="232500" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23075" TraitType="Disease" MappingType="Name" MappingValue="GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR" MappingRef="Preferred">
        <MedGen CUI="C1856304" Name="Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="145984" TraitType="Disease" MappingType="Name" MappingValue="Adult Polyglucosan Body Disease" MappingRef="Preferred">
        <MedGen CUI="C1849722" Name="Adult polyglucosan body disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

